M3 (MTHRY) ROC (Joel Greenblatt) %: 88.98% (As of Mar. 2026) — 81% Below Median


MTHRY M3 Inc MTHRY
82 GF Score
Price $5.65
GF Value $7.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is M3 ROC (Joel Greenblatt) %?

M3 MTHRY +5.21% 82 ROC (Joel Greenblatt) % is 88.98% as of Mar. 2026, which is 81% below its 10-year median of 473.22. GuruFocus rates MTHRY with a GF Score™ of 82/100 and a GF Value™ of $7.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 670 Healthcare Providers & Services companies, M3 ranks better than 91.34% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. M3's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 88.98%.

The historical rank and industry rank for M3's ROC (Joel Greenblatt) % or its related term are showing as below:

MTHRY' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 145.11   Med: 473.22   Max: 1318.06
Current: 145.11

During the past 13 years, M3's highest ROC (Joel Greenblatt) % was 1318.06%. The lowest was 145.11%. And the median was 473.22%.

MTHRY's ROC (Joel Greenblatt) % is ranked better than
91.34% of 670 companies
in the Healthcare Providers & Services industry
Industry Median: 12.485 vs MTHRY: 145.11

M3's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -27.10% per year.


M3  (OTCPK:MTHRY) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


M3 ROC (Joel Greenblatt) % Related Terms


M3 ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for M3's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3 ROC (Joel Greenblatt) % Chart

M3 Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 732.17 441.89 289.79 174.86 144.60

M3 Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.16 157.98 122.09 203.84 88.98

MTHRY vs VEEV, BTSG, TEM: ROC (Joel Greenblatt) % Comparison

For the Health Information Services subindustry, M3's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M3 ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M3's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where M3's ROC (Joel Greenblatt) % falls into.


MTHRY
82GF Score
M3 Inc MTHRY
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M3 ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(482.308 + 0 + 83.975) - (416.079 + 0 + 163.602)
=-13.398

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(470.24 + 0 + 71.533) - (438.888 + 0 + 165.091)
=-62.206

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of M3 for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=307.632/( ( (343.937 + max(-13.398, 0)) + (347.549 + max(-62.206, 0)) )/ 2 )
=307.632/( ( 343.937 + 347.549 )/ 2 )
=307.632/345.743
=88.98 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 88.98% mean?
M3 (MTHRY) has a ROC (Joel Greenblatt) % of 88.98% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on M3 and its competitors. This is 81% below median its historical median of 473.22. Over the past decade, M3's ROC (Joel Greenblatt) % has ranged from 145.11 to 1,318.06. According to the industry distribution chart, M3 ranks #58 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 8.7%.
Is M3's ROC (Joel Greenblatt) % too high?
M3's current ROC (Joel Greenblatt) % of 88.98% is 81% below median its 10-year median of 473.22. Over the past 10 years, this metric has ranged from a low of 145.11 to a high of 1,318.06. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. M3's value of 88.98% is 612.7% above this industry median. Based on the distribution chart, M3 ranks #58 out of 670 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, M3 has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's ROC (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #58 out of 670 companies for ROC (Joel Greenblatt) %. This places M3 in the top 9% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.49. M3's value of 88.98% is 612.7% above this benchmark. Historically, M3's own ROC (Joel Greenblatt) % has ranged from 145.11 to 1,318.06 over the past decade. While the company's 10-year median is 473.22 vs. the industry median of 12.49, M3 has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current ROC (Joel Greenblatt) % of 88.98% is 612.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on M3 and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current ROC (Joel Greenblatt) % is 88.98%, which is 81% below median its own 10-year median of 473.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.91, compared to a current price of $5.65 — trading 28.6% below its estimated fair value. The current ROC (Joel Greenblatt) % is 88.98%, which is 81% below median its 10-year median of 473.22 and 612.7% above the Healthcare Providers & Services industry median of 12.49. M3's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For M3 (MTHRY), the current ROC (Joel Greenblatt) % is 88.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (MTHRY) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of $5.65 is trading 28.6% below its estimated GF Value™ of $7.91. GuruFocus considers M3 to be Modestly Undervalued.

Key valuation signals for MTHRY:

  • ROC (Joel Greenblatt) %: 88.98% (81% below median its 10-year median of 473.22)
  • GF Value™: $7.91 vs. price of $5.65 (28.6% below fair value)
  • GF Score™: 82/100 with 3 warning signs
  • Industry Position: 612.7% above the Healthcare Providers & Services median (#58 of 670)

No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


M3 Business Description

Other Exchanges 2413:Japan4YC:Germany
Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
82GF Score

Get the complete analysis for MTHRY

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.65
Price
$7.91
GF Value